▷Speaker
Dr. Shanmugam has more than 20 years of experience in designing and development of conventional,
NDDS/alternate, advanced/modified drug delivery systems, and pharmaceutical platform technologies for oral and other routes of administration. His expertise includes stability, solubility/dissolution, permeability, and bioavailability enhancement techniques/technologies for challenging drugs.
Additionally, Dr. Shanmugam has published numerous research articles, holds multiple patents, and is a reviewer/editorial member of various prestigious journals. In his current position, Dr. Shanmugam is involved in the development and expansion of Adare's pharmaceutical technology portfolio and facilitates product development and co-development opportunities.
▷Lecture
The unpleasant taste is the biggest barrier for completing therapy in pediatric population because of their natural heightened taste sensitivity and aversion to bitter or unpleasant drugs. The taste masking of bitter or unpleasant drugs has demonstrated to improve the compliance up to 90% in pediatrics. So, taste masking of bitter drugs is crucial to improve medication acceptance and adherence in pediatrics. This presentation will discuss the significance of taste masking in pediatrics and various strategies of taste masking. Additionally, Adare's coacervation or phase separation process, one of the efficient taste masking technologies (Microcaps®), will be discussed in detail with pediatric-friendly ease-to-swallow dosage formats for application of taste masked multiparticulates.
Learning Objectives:
- Significance of taste masking to improve acceptance in pediatric populations
- Taste masking strategies
- Coacervation or phase separation process - Microcaps®
- Pediatric-friendly easy-to-swallow dosage formats